Gymnemagenin a Promising Drug Candidate for Management of Hyperglycemia: In-Vitro and In-Vivo Study

Javed Ahamad¹, Saima Amin², Kamran J Naquvi¹, Showkat R Mir^3*

Study of Gymnema sylvestre plant for the treatment and management of diabetes.

Abstract

Background: Diabetes mellitus is a chronic metabolic disorder resulting from absolute or relative impairments in β-cell functions, insulin resistance, or both and has been exceptionally increasing worldwide. Gymnema sylvestre is an important traditional plant used for the treatment and management of diabetes. Gymnemagenin is an aglycone part of gymnemic acids which is a bioactive component of G. sylvestre. The objective of the present study was to undertake in-vitro and in-vivo studies to generate a stronger biochemical rationale for the management of diabetes mellitus. Results: The result of the preliminary in-vitro study of gymnemagenin suggested further evaluation of the inhibition of key enzymes related to carbohydrate metabolism. Gymnemagenin showed strong α-amylase (IC₅₀ 1.17±0.02 mg/mL) and strong α-glucosidase (IC₅₀ 2.04±0.17mg/mL) inhibitory activity. The positive in-vitro enzyme inhibition tests paved the way for confirmatory in-vivo studies. The in-vivo studies demonstrated that gymnemagenin (20 mg/kg, b.w.) given orally significantly (P<0.01) reduced area under curve (AUC) in mice when challenged with oral administration of starch and sucrose separately. The reduction in AUC by gymnemagenin was comparable to that of acarbose (10 mg/kg, b.w., p.o.). Conclusion: The research findings clearly supported the traditional use of G. sylvestre in the treatment of diabetes mellitus.

Keywords: Gymnema sylvestre, gymnemagenin, diabetes mellitus, α-amylase, α-glucosidase. 

References

Ahamad, J., Alkefai, N.H.A., Amin, S., Mir, S.R. (2020b). Standardized extract from Enicostemma littorale ameliorates post-prandial hyperglycaemia in normal and diabetic rats. J. Biol. Active Prod. Nat., 10(1): 34-43.

Ahamad, J., Hasan, N., Amin, S., Mir, S.R. (2016). Swertiamarin contributes to glucose homeostasis via inhibition of carbohydrate metabolizing enzymes. J. Natural Remedies, 16(4), 125-130.

Ahamad, J., Kaskoos, R.A., Amin, S., Mir, S.R (2020c). Quantitative Analysis of Gymnemagenin in Gymnema sylvestre Leaves and in Herbal Formulation by a Validated HPTLC Method. J Biolog Active Prod Nat., 10:3, 211-219,

Ahamad, J., Naquvi, K.J., Amin, S., Mir, S.R. (2021). Gymnemic Acid-Rich Fraction from Gymnema sylvestre Leaves Ameliorates Post Prandial Hyperglycaemia in In-Vitro and In-Vivo Studies. J Biolog Active Prod Nat., 11(1), 32-41.

Ahamad, J., Naquvi, K.J., Mir, S.R., Ali, M., Shuaib, M. (2011). Review on role of natural alpha-glucosidase inhibitors for management of diabetes mellitus. Int. J. Biomed. Res., 6, 374-380.

Ahamad, J., Toufeeq, I., Khan, M. A., Ameen, M.S.M., Anwer, E.T., Uthirapathy, S., et al., (2019a). Oleuropein: A Natural Antioxidant Molecule in the Treatment of Metabolic Syndrome. Phytother. Res., 33(12), 3112-3128.

Ahamad, J., Uthirapathy, S., Ameen, M.S.M., Anwer, E.T. (2019b). Essential oil composition and antidiabetic, anticancer activity of Rosmarinus officinalis L. leaves from Erbil (Iraq). J. Essent. Oil Bear. Pl., 22(6), 1544-1553.

Ahamad, J., Uthirapathy, S., Ameen, M.S.M., Anwer, E.T., Mir, S.R. (2020a). Chemical composition and in-vitro antidiabetic effects of Olea europaea Linn. (Olive). Curr. Bioactive Comp., 16(8), 1157-1163.

Alkefai, N.H., Ahamad, J., Amin, S., Mir, S.R. (2018). Arylated gymnemic acids from Gymnema sylvestre R.Br. as potential α-glucosidase inhibitors. Phytochem Lett., 25: 196-202.

Alkefai, N.H., Sharma, M., Ahamad, J., Amin, S., Mir, S.R. (2019). New olean-15-ene type gymnemic acids from Gymnema sylvestre (Retz.) R.Br. and their antihyperglycemic activity through α-glucosidase inhibition. Phytochem. Lett., 32: 83-89.

Fabricant, D.S., and Farnsworth, N.R. (2001). The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect., 109(1), 69-75.

Flores-Bocanegra, L., Gonzalez-Andrade, M., Bye, R., Linares, E., Mata, R. (2017). New α-Glucosidase inhibitors from Salvia circinata. J. Nat. Prod., 80, 1584-1593.

Fushiki, T., Kojima, A., Imoto, T., Inoue, K., Sugimoto, E. (1992). Extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats. J. Nutr., 122, 2367-2373.

Ghani, U. (2015). Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. Eur. J. Med. Chem., 103, 133-162.

IDF Diabetes Atlas, 8th ed.; International Diabetes Federation. Available at http://www.diabetesatlas.org. Accessed June 27, (2023).

Javed Ahamad. (2023). Characterization of Essential Oil Composition of Syzygium aromaticum Linn. (Clove) by GC-MS and Evaluation of its Antioxidant Activity, Journal of Angiotherapy, 7(1), 1-5, 9358.

Kirtikar, K., Basu, B. (1998). Indian Medicinal Plants, International Book Distributors, Deharadun, India. Vol III, Pp. 1625.

Masayuki, Y., Toshiyuki, M., Masashi, K., Yuhao, L., Nubotoshi, M., Johji, Y., Hisash, M. (1997). Medicinal Foodstuffs (IX1) The inhibitors of glucose absorption from the leaves of Gymnema sylvestre R.Br. (Asclepiadaceae): structures of gymnemosides A and B. Chem. Pharm. Bull., 45(10), 1671-1676.

Nadkarni, K.M. (2007). Indian Materia Medica, Popular Prakashan, Bombay, India. Vol. I, p. 596-99.

Purves, R.D. (1992). Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the moment-curve (AUMC). J. Pharmacokinet Biopharm., 20, 211-227.

Scheen, A.J. (2003). Is there a role for α-glucosidase inhibitors in the prevention of type 2 diabetes mellitus? Drugs, 63, 933-951.

Subramanian, R., Asmawi, M.Z., Sadikun, A. (2008). In-vitro α-glucosidase and α-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim. Pol., 55(2), 391-398.

Sugihara, Y., Nojima, H., Matsuda, H., Murakami, T., Yoshikawa, M., Kimura, I. (2000). Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptozotocin-diabetic mice. J. Asian Nat. Prod. Res., 2(4), 321-327.

Wen-Cai, Y., Zhang, Q.W., Liu, X., Che, C.T., Zhao, S.X. (2000). Oleanane saponins from Gymnema sylvestre. Phytochem., 53, 893-899.